BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Diabetes. Apr 15, 2026; 17(4): 117489
Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.117489
Serum 25-hydroxyvitamin D and peripheral thyroid hormone sensitivity in euthyroid type 2 diabetes: Linear estimates and low-range threshold
Chun-Yan Zhu, Zi-Ru Fang, Liang-Yan Hua, Hui Jin, Xin-Yi Xu, Xiang-Lan Liu, Yi-Ming Zhang, Zi-Chen Rao
Chun-Yan Zhu, Zi-Ru Fang, Liang-Yan Hua, Xin-Yi Xu, Xiang-Lan Liu, Yi-Ming Zhang, Zi-Chen Rao, Department of Endocrinology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou 324000, Zhejiang Province, China
Hui Jin, Department of Clinical Nutrition, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou 324000, Zhejiang Province, China
Co-first authors: Chun-Yan Zhu and Zi-Ru Fang.
Co-corresponding authors: Yi-Ming Zhang and Zi-Chen Rao.
Author contributions: Zhu CY, Fang ZR, Zhang YM and Rao ZC conceptualized the study; Zhang YM, Rao ZC and Zhu CY developed the methodology; Fang ZR performed the software analysis (EmpowerStats); Zhang YM and Rao ZC conducted the validation; Zhu CY and Fang ZR performed the formal analysis; Xu XY, Hua LY, Jin H, Zhu CY and Liu XL carried out the investigation; Hua LY, Zhu CY and Liu XL provided resources; Xu XY, Hua LY, Jin H, Zhu CY and Liu XL curated the data; Zhu CY prepared the visualization; Zhu CY and Fang ZR drafted the manuscript; Zhang YM, Rao ZC, Zhu CY and Fang ZR reviewed and edited the manuscript; Zhang YM and Rao ZC supervised the study; Rao ZC and Hua LY managed project administration; Zhu CY and Fang ZR contributed equally and share first authorship; Rao ZC and Zhang YM contributed equally and share corresponding authorship.
Institutional review board statement: This study was approved by the Ethics Committee of Quzhou People’s Hospital, Wenzhou Medical University (Approval No. 2022-110).
Informed consent statement: Written informed consent was waived by the Ethics Committee because this retrospective study used de-identified data and involved minimal risk.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Data sharing statement: De-identified data are available from the corresponding author upon reasonable request and subject to institutional and privacy restrictions.
Corresponding author: Zi-Chen Rao, MD, Department of Endocrinology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, No. 100 Minjiang Dadao, West District, Quzhou 324000, Zhejiang Province, China. rzc1522@wmu.edu.cn
Received: December 9, 2025
Revised: January 10, 2026
Accepted: February 11, 2026
Published online: April 15, 2026
Processing time: 127 Days and 2.8 Hours
Abstract
BACKGROUND

Vitamin D insufficiency is common in type 2 diabetes (T2D) and may relate to peripheral thyroid hormone sensitivity. We hypothesized that higher serum 25-hydroxyvitamin D [25(OH)D] is associated with a higher free triiodothyronine-to-free thyroxine ratio in euthyroid adults, with a nonlinear pattern.

AIM

To evaluate the association between serum 25(OH)D and the free triiodothyronine-to-free thyroxine ratio in euthyroid adults with T2D.

METHODS

We conducted a cross-sectional study in a real-world cohort from a metabolic management center in China. Euthyroid adults with T2D were enrolled (n = 1408). Free triiodothyronine, free thyroxine, thyroid-stimulating hormone, and 25(OH)D were measured at the same visit. Analyses of 25(OH)D were restricted to participants with available measurements (n = 1271). Multivariable linear regression modeled the ratio scaled by 100. Restricted cubic splines and two-piecewise models assessed nonlinearity and estimated a threshold. Prespecified subgroups included age, sex, body mass index, current smoking, and current drinking.

RESULTS

Higher 25(OH)D was associated with a higher scaled ratio in the fully adjusted model (β = 0.088 per 1 ng/mL; 95%CI: 0.037-0.139; P < 0.001), equivalent to +0.88 units per 10 ng/mL. Spline and segmented analyses indicated a low-range threshold at 14.7 ng/mL (95%CI: 12.85-16.11). The slope was steeper below the threshold and not significant above it. Estimates were numerically larger in participants aged ≥ 60 years, but age interaction was not significant (P for interaction = 0.113). A drinking interaction was observed: The association was positive in non-drinkers but null in current drinkers (P for interaction = 0.0115). Interaction testing was exploratory and not adjusted for multiple comparisons.

CONCLUSION

In euthyroid adults with T2D, higher 25(OH)D is associated with a higher free triiodothyronine-to-free thyroxine ratio, mainly at low 25(OH)D concentrations.

Keywords: 25-hydroxyvitamin D; Free triiodothyronine-to-free thyroxine ratio; Thyroid hormone sensitivity; Type 2 diabetes; Nonlinear association; Restricted cubic splines; Piecewise regression

Core Tip: In a real-world cohort of euthyroid adults with type 2 diabetes, we examined the association between serum 25-hydroxyvitamin D and the free triiodothyronine-to-free thyroxine (FT3/FT4) ratio, a pragmatic circulating proxy of peripheral thyroid hormone sensitivity. Using multivariable models with restricted cubic splines and segmented regression, we identified a low-range threshold around 14.7 ng/mL: The positive gradient was steeper below this level and was attenuated above it. The overall pattern was broadly consistent across prespecified subgroups, with attenuation among current drinkers. These findings are associative and require longitudinal or interventional confirmation.